COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,741 Articles (22,502 medRxiv, 8,239 bioRxiv)

Most recent first Previous |  Page 11: Articles 101-110  | Next

A Plasma Membrane Vesicle Imaging-Based Platform for Studying Membrane Fusion
Yosibash, I., Khan, S., Lichtenstein, A., Dharan, R., Vaknin, A., Daniel, S., Avinoam, O., Sorkin, R.
10.1101/2025.05.29.656808 — Posted: 2025-05-30
A non-spike nucleocapsid R204P mutation in SARS-CoV-2 Omicron XEC enhances inflammation and pathogenicity
Tsujino, S., Tsuda, M., Ito, J., Deguchi, S., Taha, T. Y., Nasser, H., Wang, L., Rosecrans, J., Suzuki, R., Suzuki, S., Yoshimatsu, K., Ott, M., The Genotype to Phenotype Japan (G2P-Japan) Consortium, , Ikeda, T., Takayama, K., Sato, K., Tanaka, S., Tamura, T., Fukuhara, T.
10.1101/2025.05.28.656516 — Posted: 2025-05-30
Tracing SARS-CoV-2 Evolution in Algeria: Insights from 2020-2023
Ezahedi, F. E., Derrar, F., Abraham, A., Zeghbib, S.
10.1101/2025.05.28.656620 — Posted: 2025-05-30
A Community-Engaged Public Health Research and Outreach Program for Migrant and Racialized Workers in Meat Processing to Mitigate COVID-19 Inequities
Fabreau, G. E., Norrie, E. C., Holdbrook, L., Antonio, M., Essar, M. Y., Youssef, M., Sahilie, A., Yemane, M., Ramirez-Cerino, E., Hassan, N., Grewal, R., Hussain, Z., Altahsh, D., Magwood, O., Ammar, S., Santana, M., Bharwani, A., Nielssen, I., Edwards, S. T., Spitzer, D., Coakley, A., Pottie, K.
10.1101/2025.05.28.25327793 — Posted: 2025-05-30
Impact of COVID-19 on Antenatal Care Utilization and Health Provider Response in Tamale, Ghana: A Mixed-Method Study
Mensah, R., Otupiri, E., Addae, E., Yankyera, B., Sarfo, B.
10.1101/2025.05.27.25327765 — Posted: 2025-05-29
SARS-CoV-2 vaccination and chemosensory dysfunction after COVID-19
Koyama, S., Mucignat-Caretta, C., Klyuchnikova, M. A., Laktionova, T. K., Kopishinskaia, S., Kvasha, I. G., Ye, J., Cantone, E., Parsa, S., Guardia, M. D., Hivert, V., Chauquet, S., Chen, J., Centorame, G., Parma, V., Ohla, K., Voznessenskaya, V. V., Hwang, L.-D.
10.1101/2025.05.28.25328470 — Posted: 2025-05-29
2024-2025 BNT162b2 COVID-19 vaccine effectiveness in non-immunocompromised adults: mid-season estimates from vaccine registries in two states linked to administrative claims
Andersen, K. M., Ahi, T., Mateus, J. S., Yu, T., Zhou, A., Lopez, S. M. C., Puzniak, L. A.
10.1101/2025.05.28.25327615 — Posted: 2025-05-29
Clinical progression parameters associated with SARS-CoV-2, influenza, and respiratory syncytial virus infections
Parker, N. T., Hong, V., Davis, G. S., Pomichowski, M., Reyes, I. A., Xie, F., Mueller, N. F., Rodriguez-Barraquer, I., Tartof, S. Y., Lewnard, J. A.
10.1101/2025.05.28.25328531 — Posted: 2025-05-29
The Potential Clinical and Economic Impact of the Next-Generation COVID-19 mRNA-1283 Vaccine in Canada
Fust, K., Kohli, M., Cartier, S., Joshi, K., Van de Velde, N., Beck, E., Blake, M.
10.1101/2025.05.29.25328577 — Posted: 2025-05-29
Socio-demographic inequalities in COVID-19 health care access and experiences in the United Kingdom: intersectional and mixed-methods analyses of open and closed questions in a prospective cohort study
Cheetham, N. J., Beattie, A., Comery, A. B., Bowyer, V., The COVID Symptom Study Biobank Consortium, , Carpentieri, J. D., Steves, C. J.
10.1101/2025.05.29.25328562 — Posted: 2025-05-29

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).